- Home
- Articles
- north america
- cancer cell targeting
Cancer Cell Targeting Articles & Analysis
21 articles found
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. ...
Researchers are increasingly focused on engineering antibodies that can selectively target specific cancer cells or diseased tissues while minimizing off-target effects. ...
Understanding Radioactive Drug Conjugates Radioactive drug conjugates are engineered to deliver radiation directly to cancer cells while sparing healthy tissues. This specificity is achieved by linking a radioactive isotope to a monoclonal antibody or small molecule that targets specific cancer antigens. ...
When mutated, Rb loses its ability to control division, often leading to cancer. Recent Research in Cell Cycle Regulation 1. Alternative Cell Cycle Pathways A recent study identified an alternative cell cycle mechanism in certain cancer cells, revealing how some tumors bypass traditional ...
Alfa Cytology unveils advanced cancer immunotherapy development services. Alfa Cytology, a renowned services supplier in oncology, has recently introduced its groundbreaking cancer immunotherapy development services. ...
This article explores the profound impact of nanotechnology on drug delivery systems and its correlation with formulation development services Enhanced Drug Delivery and Targeting One of the most significant contributions of nanotechnology to pharmaceutical formulations is its ability to enhance drug delivery and targeting. Through the design and utilization of ...
This cutting-edge initiative represents a major advancement in creating more precise and versatile cancer treatment paradigms. As the landscape of cancer treatment continues to evolve, there is a growing need for innovative and personalized therapeutic approaches. Conventional therapies often fall short in their ability to selectively target ...
Bladder cancer, characterized by the uncontrolled proliferation of abnormal cells within the bladder lining, poses significant treatment challenges due to its potential to invade surrounding tissues and surrounding propensity for recurrence. The conventional therapeutic landscape has often fallen short in terms of specificity and effectiveness, necessitating a ...
Ensure Specificity and TargetingThe main advantage of ADC lies in its high specificity for specific cancer cell surface antigens. Biological activity analysis can verify whether ADC can accurately identify and bind to target antigens. This not only helps ensure therapeutic effects but also reduces non-specific damage to healthy ...
BOC Sciences offers a variety of linkers, including cleavable linkers, non-cleavable linkers, and pH-sensitive linkers, to accommodate different drug payloads and target antigens. These linkers are designed to be stable in circulation but release cytotoxicity upon internalization by target cancer cells, ensuring maximum ...
The antibody component specifically targets surface antigens on specific cancer cells, while the drug component is responsible for killing these bound cancer cells. ...
In the field of medicine, effectively delivering drugs to the target site in the body is crucial for successful treatment. Over the years, several innovative drug delivery systems have been developed to improve drug efficacy and patient outcomes. ...
In addition to causing degradation of the target protein HER2, SignalTAC also downregulates downstream signaling (PI3K/AKT/mTOR) and promotes apoptosis and inhibits the proliferation of HER2-driven cancer cells. ...
In the search for innovative and effective ways to target cancer, we are faced with more than just a challenging problem; we are faced with our own cells as opponents. ...
Gold nanocages can absorb light and heat, creating a photothermal effect that can kill cells. In fact, people use this effect to kill cancer cells. What are the differences between gold nanocages and nanorods? ...
Genetic mutations in cells are an important cause of cancer development, progression, and drug resistance. How to quickly and accurately translate massive tumor genomic information into safe and effective cancer targeted therapies in clinical practice is a scientific frontier today. ...
The researchers expose us to a radically different way of thinking in this article: instead of working on T cells, they focus on changing cancer cell antigens. They employed antibodies to deliver viral antigens to the tumor location and trigger virus-specific T lymphocytes to target cancer cells, ...
Novel cytotoxic drugs New cytotoxic drugs have been developed to target cancer cells with low antigen expression or resistance to auristatins or maytansinoids. ...
Gabrielle is researching novel α-helical peptide inhibitors of breast cancer oncogene LMO4. She has been working to redesign the peptide protein interface of LMO4 by replacing the traditional β-strand binding partners with novel inhibitory α-helical ones and designing a high throughput screening mechanism to identify these peptides. ...